PRX-00023 Therapy in Localization-Related Epilepsy

NCT01281956 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Epilepsy
Epilepsy, Temporal Lobe
Partial Epilepsy

Interventions

DRUG: PRX-00023
DRUG: Placebo

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)